or Try an Advanced Search...

    Technical Analysis for TNFA - TNF Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.45 -10.49% -0.17
    TNFA closed down 10.49 percent on Tuesday, October 1, 2024, on 29 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Up
    Historical TNFA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -10.49%
    Bearish Engulfing Bearish -5.23%
    Outside Day Range Expansion -5.23%
    Wide Bands Range Expansion -5.23%
    Inside Day Range Contraction -13.17%
    Wide Bands Range Expansion -13.17%
    Gapped Up Strength -13.17%
    Older End-of-Day Signals for TNFA ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 20 DMA about 11 hours ago
    20 DMA Support about 14 hours ago
    Rose Above Previous Day's High about 14 hours ago
    Outside Day about 14 hours ago
    Down 5% about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TNFA Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Pain Autoimmune Disease Disorders Chronic Pain Depression Epilepsy Analgesics Drug Products Cannabidiol Neurodegenerative Disease Sjögren Syndrome Anticonvulsants

    Is TNFA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 21 TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline
    Jul 22 MyMD Pharma announces rebranding to TNF Pharmaceuticals
    See more TNFA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.16
    52 Week Low 1.1601
    Average Volume 45,555
    200-Day Moving Average 0.00
    50-Day Moving Average 1.70
    20-Day Moving Average 1.46
    10-Day Moving Average 1.42
    Average True Range 0.15
    RSI (14) 45.65
    ADX 22.29
    +DI 21.80
    -DI 21.91
    Chandelier Exit (Long, 3 ATRs) 1.36
    Chandelier Exit (Short, 3 ATRs) 1.61
    Upper Bollinger Bands 1.80
    Lower Bollinger Band 1.12
    Percent B (%b) 0.48
    BandWidth 47.12
    MACD Line -0.06
    MACD Signal Line -0.09
    MACD Histogram 0.0365
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.78
    Resistance 3 (R3) 1.81 1.73 1.72
    Resistance 2 (R2) 1.73 1.65 1.71 1.71
    Resistance 1 (R1) 1.59 1.59 1.55 1.56 1.69
    Pivot Point 1.51 1.51 1.49 1.49 1.51
    Support 1 (S1) 1.37 1.43 1.33 1.34 1.21
    Support 2 (S2) 1.29 1.37 1.28 1.19
    Support 3 (S3) 1.15 1.29 1.18
    Support 4 (S4) 1.12